drugset / Trial / NCT00026078

Docetaxel and Ifosfamide in Treating Women With Metastatic Breast Cancer

NCT00026078 ↗

Phase 2 Unknown 42 enrolled Grupo Oncologico Cooperativo del Sur
Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of docetaxel and ifosfamide in treating women who have metastatic breast cancer.

Timeline

Start
2001-03
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Docetaxel Small molecule — Intravenous
Subject Ifosfamide Small molecule — Intravenous

Indications